Suchergebnisse - "Guan, Xiuwen"

PubPharm (18)

1

Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer

enthalten in: Signal transduction and targeted therapy | 2023

von Guan, X. | Ma, F. | Li, Q. | +7

2

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients

enthalten in: Cancer medicine | 2022

von Liu, B. | Yi, Z. | Guan, Y. | +10

3

Cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy

enthalten in: Journal of advanced research | 2022

von Jiang, M. | Zhao, L. | Cui, X. | +5

4

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

enthalten in: Cancer cell | 2021

von Zhang, Y. | Chen, H. | Mo, H. | +17

CommentIn: Cancer Cell. 2021 Dec 13;39(12):1562-1564. - PMID 34767761

5

The molecular tumor burden index as a response evaluation criterion in breast cancer

enthalten in: Signal transduction and targeted therapy | 2021

von Yi, Z. | Ma, F. | Rong, G. | +10

6

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

enthalten in: International journal of cancer | 2020

von Ma, F. | Guan, Y. | Yi, Z. | +16

ErratumIn: Int J Cancer. 2020 Jun 15;146(12):E8. - PMID 32320496

7

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

enthalten in: Cancer communications (London, England) | 2019

von Lin, S. | Yue, J. | Guan, X. | +11

8

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients : A Phase I Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Li, Q. | Guan, X. | Chen, S. | +16

9

Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2019

von Guan, X. | Lin, L. | Chen, J. | +5

10

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

enthalten in: Cancer communications (London, England) | 2019

von Guan, X. | Ma, F. | Li, C. | +13